Inspire Investing’s Pacira BioSciences PCRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$510K	Buy	22,574 +4,616	+26%	+$103K	0.03%	806
2025 Q4	$465K	Buy	17,958 +556	+3%	+$13.2K	0.04%	699
2025 Q3	$448K	Buy	17,402 +846	+5%	+$20.8K	0.04%	729
2025 Q2	$396K	Buy	16,556 +2,868	+21%	+$72.3K	0.04%	358
2025 Q1	$340K	Sell	13,688 -7,347	-35%	-$176K	0.04%	700
2024 Q4	$396K	Sell	21,035 -6,439	-23%	-$113K	0.04%	737
2024 Q3	$413K	Buy	27,474 +15,138	+123%	+$259K	0.04%	475
2024 Q2	$353K	Buy	12,336 +205	+2%	+$5.83K	0.04%	494
2024 Q1	$354K	Buy	12,131 +675	+6%	+$20.7K	0.04%	768
2023 Q4	$387K	Buy	11,456 +1,526	+15%	+$44.6K	0.04%	445
2023 Q3	$305K	Buy	9,930 +2,083	+27%	+$75.1K	0.04%	760
2023 Q2	$314K	Buy	7,847 +1,173	+18%	+$48.5K	0.04%	542
2023 Q1	$272K	Buy	6,674 +595	+10%	+$23.7K	0.03%	669
2022 Q4	$235K	Buy	6,079 +2,214	+57%	+$108K	0.03%	680
2022 Q3	$206K	Buy	3,865 +188	+5%	+$10.5K	0.03%	649
2022 Q2	$214K	Buy	3,677 +574	+18%	+$37.6K	0.03%	379
2022 Q1	$237K	Sell	3,103 -1,015	-25%	-$67.7K	0.03%	433
2021 Q4	$248K	Buy	4,118 +91	+2%	+$5.02K	0.03%	592
2021 Q3	$226K	Buy	4,027 +67	+2%	+$3.86K	0.03%	684
2021 Q2	$240K	Buy	3,960 +120	+3%	+$7.6K	0.03%	568
2021 Q1	$269K	Sell	3,840 -4	-0.1%	-$286	0.04%	551
2020 Q4	$230K	Buy	+3,844	New	+$225K	0.05%	566
2020 Q3	–	Sell	-4,154	Closed	-$218K	–	537
2020 Q2	$218K	Sell	4,154 -1,439	-26%	-$60.1K	0.08%	398
2020 Q1	$188K	Buy	+5,593	New	+$232K	0.08%	473
2018 Q1	–	Sell	-1,298	Closed	-$59K	–	555
2017 Q4	$59K	Buy	+1,298	New	+$51.4K	0.05%	358